Serum microRNA panels predict bariatric surgery outcomes

Area of Science:

• Metabolic Surgery
• Molecular Biology
• Obesity Research

Background:

• Bariatric surgery is a key treatment for obesity, but weight loss varies.
• MicroRNAs (miRNAs) play roles in adipose tissue regulation.
• A serum miRNA biomarker for predicting bariatric surgery outcomes is currently lacking.

Purpose of the Study:

• To identify a serum miRNA signature predictive of sustained weight loss after bariatric surgery.
• To evaluate the potential of this signature as a clinical biomarker.

Main Methods:

• Serum miRNA microarray analysis was performed on patients with effective vs. ineffective weight loss post-bariatric surgery.
• Effective response was defined as >55% excess weight loss at 6 months.
• Bioinformatic analysis explored the functional pathways targeted by identified miRNAs.

Main Results:

• Three miRNAs (miR-31-5p, miR-328-3p, miR-181a-5p) showed differential expression between responders and non-responders.
• Specific serum miRNA ratios (miR-328-3p/miR-31-5p or miR-181a-5p/miR-31-5p) combined with BMI predicted treatment effectiveness.
• Predicted miRNA targets are involved in the AMP-activated protein kinase signaling pathway.

Conclusions:

• A circulating miRNA signature, incorporating BMI, can serve as a clinical biomarker for predicting bariatric surgery effectiveness.
• This finding may aid in personalizing obesity treatment strategies.